scholarly journals Effect of Camel Milk on Blood Sugar and Lipid Profile of Patients With Type 2 Diabetes: A Pilot Clinical Trial

2014 ◽  
Vol 13 (1) ◽  
Author(s):  
Hanieh Sadat Ejtahed ◽  
Amir Niasari Naslaji ◽  
Parvin Mirmiran ◽  
Maryam Zraif Yeganeh ◽  
Mehdi Hedayati ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Lipid Profile ◽  
Blood Sugar ◽  
Camel Milk

Effect of camel milk on glycaemic control and lipid profile of patients with type 2 diabetes: Randomised controlled clinical trial

2020 ◽  
Vol 101 ◽  
pp. 104568 ◽  
Author(s):  
Zahra Fallah ◽  
Hanieh-Sadat Ejtahed ◽  
Parvin Mirmiran ◽  
Amir Niasari Naslaji ◽  
Aliakbar Moosavi Movahedi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Glycaemic Control ◽  
Lipid Profile ◽  
Camel Milk ◽  
Controlled Clinical Trial ◽  
Randomised Controlled Clinical Trial ◽  
Randomised Controlled

scholarly journals Effect of camel milk in comparison with cow milk on blood glucose and lipid profile in patients with type 2 diabetes: A randomized clinical trial

2021 ◽  
Vol 8 (1) ◽  
pp. 15
Author(s):  
Samira Eshghinia ◽  
Mahdieh Margdarinejad ◽  
Akram Sanagoo ◽  
Fatemeh Mohammad Zadeh ◽  
Saeed Amirkhanloo ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Blood Glucose ◽  
Lipid Profile ◽  
Randomized Clinical Trial ◽  
Camel Milk ◽  
Cow Milk

scholarly journals Evaluation of Fasting Blood Sugar and Lipid Profile in Patients with Type 1 and Type 2 Diabetes and Normoglycemic Individuals in Gorgan, Northeastern

2019 ◽  
Vol 3 (1) ◽  
pp. 6-10 ◽  
Author(s):  
Nasim Arab Sarhadi ◽  
Mohammad-ebrahim Fakhreddin-nejad ◽  
Mohammad-hassan Rajabi ◽  
Soleiman Mokarrari ◽  
Ebrahim Naghipour ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Lipid Profile ◽  
Blood Sugar ◽  
Fasting Blood Sugar

Multimedia education program and nutrition therapy improves HbA1c, weight, and lipid profile of patients with type 2 diabetes: a randomized clinical trial

Endocrine ◽  
2017 ◽  
Vol 58 (2) ◽  
pp. 236-245 ◽  
Author(s):  
Lubia Velázquez–López ◽  
Abril Violeta Muñoz-Torres ◽  
Patricia Medina-Bravo ◽  
Jenny Vilchis-Gil ◽  
Miguel Klϋnder-Klϋnder ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Lipid Profile ◽  
Randomized Clinical Trial ◽  
Education Program ◽  
Nutrition Therapy ◽  
Multimedia Education

scholarly journals Effectiveness of ginger in reducing metabolic levels in people with diabetes: a randomized clinical trial

2020 ◽  
Vol 28 ◽  
Author(s):  
Gerdane Celene Nunes Carvalho ◽  
José Claudio Garcia Lira-Neto ◽  
Márcio Flávio Moura de Araújo ◽  
Roberto Wagner Júnior Freire de Freitas ◽  
Maria Lúcia Zanetti ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Blood Sugar ◽  
Zingiber Officinale ◽  
Secondary Outcome ◽  
Control Group ◽  
Double Blind ◽  
Experimental Group ◽  
Hba1c Levels

Objective: to evaluate the effectiveness of ginge (Zingiber officinale) in reducing blood sugar and lipid levels in people with type 2 diabetes. Method: a randomized and double-blind clinical trial conducted with people with type 2 diabetes in primary care facilities. The study included individuals aged between 20 and 80 years old, using oral antidiabetic drugs and with HbA1c levels between 6.0% and 10%. The participants were paired 1:1, allocated in two distinct groups, and randomized in blocks, based on their HbA1c levels. In the experimental group, the participants used 1.2g of ginger and, in the control group, 1.2g of placebo, daily for 90 days. The primary outcome was a reduction in fasting blood sugar and HbA1c, and the secondary outcome was a reduction in lipids and HOMA-IR. 103 individuals completed the study, 47 in the experimental group and 56 in the control group. Results: the participants in the experimental group showed a greater reduction in the blood glucose and total cholesterol values compared to the control group. Conclusion: the use of ginger can help in the treatment of people with diabetes, and data support the inclusion of this herbal drug in the clinical practice of nurses. RBR-2rt2wy

scholarly journals The Effect of Combined Herbal Capsule on Glycemic Indices and Lipid Profile in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Rezvan Ghafarzadegan ◽  
Javad Javaheri ◽  
Mina Asgari ◽  
Mohammad Golitaleb ◽  
Fatemeh Maraki ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Type 2 Diabetes Mellitus ◽  
Lipid Profile ◽  
Intervention Group ◽  
Control Group ◽  
Controlled Clinical Trial ◽  
Glycemic Indices

Objectives: The present study aimed to investigate the potential effects of the combined herbal capsule (CHC), as a nutritional supplement, on glycemic indices (GIs) and lipid profile (LP) of patients with type 2 diabetes mellitus (T2DM). Methods: Following a randomized, single-blind, placebo-controlled clinical trial, the current study was conducted on 80 cases with T2DM who were randomly assigned into two groups of treatment (CHCs; n = 40) and control (placebo; n = 40). Both groups received the intervention (500 mg capsules) twice a day for three months, without changes in the previous dose of oral anti-hyperglycemic drugs. The GI and LP levels were measured before the intervention and three months later to investigate the potential efficacy of the interventions. Results: For those in the intervention group, the mean GI [i.e., fasting blood sugar, two hours postprandial (2hpp), and HbA1c] was significantly different after 3 months (P < 0.05). The GI- and LP-related outcomes (TG, LDL-C except for TC) were improved after 3-month of receiving the intervention compared to the control group; however, the observed improvement was no statistically significant (P > 0.05). The HDL-C level was also significantly improved in the intervention group compared to the control group (P < 0.05). Conclusions: This study demonstrated that receiving CHCs could improve GI and LP levels (TG, LDL-C, and HDL-C, except for TC), which indicates its potential to control T2DM. Moreover, no significant side effect was observed in the intervention group. It can be argued that the use of CHCs, as adjuvant therapy, in combination with conventional hypoglycemic and lipid-lowering drugs, as well as following a modified lifestyle, not only can significantly enhance glycemic control but also may prevent T2DM complications.

Sign in / Sign up

Export Citation Format

Share Document